Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) Sees Large Increase in Short Interest

Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) saw a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 731,000 shares, an increase of 15.7% from the January 15th total of 631,800 shares. Based on an average daily trading volume, of 1,930,000 shares, the days-to-cover ratio is presently 0.4 days.

Petros Pharmaceuticals Price Performance

PTPI stock traded up $0.05 during trading on Friday, hitting $0.29. 107,200,541 shares of the company’s stock traded hands, compared to its average volume of 383,633. The business has a fifty day simple moving average of $0.32 and a two-hundred day simple moving average of $0.33. The company has a debt-to-equity ratio of 1.58, a quick ratio of 0.74 and a current ratio of 0.85. Petros Pharmaceuticals has a 1 year low of $0.22 and a 1 year high of $1.76.

About Petros Pharmaceuticals

Petros Pharmaceuticals, Inc, a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED).